We are live on ! Find out more
TRIB

Trinity Biotech
TRIB

41 hedge funds and large institutions have $30.2M invested in Trinity Biotech in 2018 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 15 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.23% less ownership

Funds ownership: 3.02% → 2.79% (-0.23%)

13% less funds holding

Funds holding: 47 → 41 (-6)

47% less capital invested

Capital invested by funds: $57.2M → $30.2M (-$27M)

53% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 15

86% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 7

Holders
41
Holders Change
-6
Holders Change %
-12.77%
% of All Funds
0.91%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
7
Reduced
15
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Stonehill Capital Management
New York
+$2.37M
2
FM
Fondren Management
Texas
+$592K
3
HAIM
Hunter Associates Investment Management
Pennsylvania
+$465K
4
HA
Heartland Advisors
Wisconsin
+$285K
5
BlackRock
BlackRock
New York
+$190K

Top Sellers

Rank Fund Capital Flow
1
SM
Senvest Management
New York
-$4.02M
2
LAM
Lapides Asset Management
Connecticut
-$1.64M
3
Russell Investments Group
Russell Investments Group
United Kingdom
-$1.55M
4
Boston Partners
Boston Partners
Massachusetts
-$394K
5
PIM
Paradice Investment Management
Colorado
-$171K
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$31K – – –
Verition Fund Management
27
Verition Fund Management
Connecticut
$28K – – –
WS
28
Wedbush Securities
California
$27K -$13.7K -890 -27%
TRCT
29
Tower Research Capital (TRC)
New York
$27K -$8.91K -577 -20%
US Bancorp
30
US Bancorp
Minnesota
$24K – – –
Northern Trust
31
Northern Trust
Illinois
$23K -$648 -42 -2%
WAS
32
WESPAC Advisors SoCal
California
$11K – – –
ECM
33
Engine Capital Management
New York
$10K – – –
Bank of Montreal
34
Bank of Montreal
Ontario, Canada
$7K – – –
JCM
35
Jacobi Capital Management
Pennsylvania
$5K – – –
Bank of America
36
Bank of America
North Carolina
$3K +$957 +62 +47%
LTFS
37
Ladenburg Thalmann Financial Services
Florida
$1K – – –
Royal Bank of Canada
38
Royal Bank of Canada
Ontario, Canada
$1K – – –
SM
39
Senvest Management
New York
– -$4.02M -200,798 Closed
VF
40
Virtu Financial
New York
– -$135K -6,754 Closed
Acadian Asset Management
41
Acadian Asset Management
Massachusetts
– -$23K -1,163 Closed
WT
42
Whittier Trust
California
– -$4K -200 Closed
UBS Group
43
UBS Group
Switzerland
– -$2K -113 Closed
IA
44
IFP Advisors
Florida
– -$1K -48 Closed
1
2

TRIB Hedge Fund Activity: Q4 2018 in Review

41 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Trinity Biotech (TRIB) for Q4 2018, worth a combined $30.2M — down 47% from $57.2M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of TRIB and 1 opened new positions — a net loss of 6 holders — while 15 trimmed existing stakes and 7 added.

The largest buyer was Stonehill Capital Management, adding an estimated $2.37M. The largest seller was Senvest Management, exiting entirely with an estimated $4.02M sold.

  • 41 institutional investors held Trinity Biotech (TRIB) as of Q4 2018, down from 47 in Q3 2018.
  • Funds reported $30.2M of Trinity Biotech stock for Q4 2018, down 47% quarter-over-quarter.
  • 1 fund opened new Trinity Biotech positions in Q4 2018 and 7 closed out, a net change of -6 holders.
  • The largest Trinity Biotech buyer in Q4 2018 was Stonehill Capital Management, an estimated $2.37M added.
  • The largest Trinity Biotech seller in Q4 2018 was Senvest Management, an estimated $4.02M sold.

Based on aggregated 13F filings for Q4 2018.